Literature DB >> 26836057

Novel technique to treat melasma in Chinese: The combination of 2940-nm fractional Er:YAG and 1064-nm Q-switched Nd:YAG laser.

Wei Cheng Brian Anthony Tian1.   

Abstract

Melasma is one of the most common pigmented lesions in Chinese women. Although topical therapies are the mainstay treatment, lasers are being used increasingly to treat pigmented lesions. Laser treatment of melasma is however still controversial. This is because lasers have not been able to produce complete clearance of melasma and recurrence rates are high. Laser treatments also cause complications such as hypopigmentation and post-inflammatory hyperpigmentation. In this article, we report on a novel technique using a combination of fractional 2940-nm Er:YAG and 1064-nm Q-switched Nd:YAG lasers. We achieved a rapid improvement in two cases of melasma in Chinese type III skin. The improvement was seen rapidly within a month of treatment. Follow-up at 6 months showed sustained results with no complications. This novel technique is able to safely confer excellent and sustained clearance within a short treatment time.

Entities:  

Keywords:  Chinese; Er:YAG; Melasma; Nd:YAG; laser; novel

Mesh:

Year:  2016        PMID: 26836057     DOI: 10.3109/14764172.2015.1063662

Source DB:  PubMed          Journal:  J Cosmet Laser Ther        ISSN: 1476-4172            Impact factor:   2.247


  3 in total

Review 1.  Melasma: A Condition of Asian Skin.

Authors:  Michelle X Wu; Ruth Antony; Harvey N Mayrovitz
Journal:  Cureus       Date:  2021-04-10

2.  Lasers in Melasma: A Review with Consensus Recommendations by Indian Pigmentary Expert Group.

Authors:  Rashmi Sarkar; Sanjeev Aurangabadkar; T Salim; Anupam Das; Swapnil Shah; Imran Majid; Mohan Singh; G Ravichandran; Kiran Godse; Shehnaz Arsiwala; Latika Arya; Narendra Gokhale; Nilendu Sarma; R G Torsekar; Sidharth Sonthalia; V K Somani
Journal:  Indian J Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.494

3.  A Retrospective Analysis of Er:YAG Laser Treatment in Solar Lentigines: Our Clinical Observations.

Authors:  Ezgi Aktas Karabay; Neslihan Fisek Izci
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2020-05-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.